AirSculpt Technologies, Inc.
AIRSHealthcareNASDAQMedical Care Facilities · Last scanned Oct 24, 2026
Scan Results
Daily timeframeAirSculpt Technologies, Inc., together with its subsidiaries, focuses on operating as a holding company for EBS Intermediate Parent LLC that provides body contouring procedure services in the United. At a $86.5M market cap, AirSculpt Technologies, Inc. ranks as a micro-cap company within healthcare. The company offers AirSculpt, a body contouring treatment that removes fat and tightens skin while sculpting targeted areas of the body in a minimally invasive procedure.
Market Cap
$86.5M
Beta
2.33
P/E (TTM)
—
P/E (Fwd)
-120.00
EPS (TTM)
$-0.17
EPS (Fwd)
$-0.01
ROE
-12.0%
ROA
-1.9%
Cash
$18.8M
Total Debt
$70.5M
Free CF
$8.0M
52W Change
-89.5%
Annual Financials
Cash vs Debt
Where AIRS stands vs its 150-day and 200-day moving averages
As of the October 20, 2026 close, AIRS finished 63.98% below its 150-day moving average ($3.47) and 60.44% below its 200-day moving average ($3.16). This snapshot is end-of-day data shown with a five-trading-day delay on the free plan; Premium members see readings from the latest close.
Is AIRS overbought or oversold?
At the October 20, 2026 close, AIRS's RSI(14) was 22.1, in oversold territory (below 30). The MACD histogram was negative, so short-term momentum leaned bearish at that close. These readings are historical, refresh daily after market close, and are not investment advice.
The company holds $18.8M in cash, though total debt stands at $70.5M. This level of leverage is common in the industry but worth monitoring as interest rate conditions evolve. Annual free cash flow of $8.0M supports ongoing capital allocation decisions and provides a cushion against unexpected expenses or downturns. ROE of -12.0% points to negative capital efficiency, indicating how much profit the company produces per dollar of shareholder equity. Revenue has pulled back from $168.8M (2022) to $151.8M (2025), a 10% decline worth watching.
A beta of 2.33 means AIRS is more volatile than average. Investors should be prepared for wider price swings relative to broader indices. No single metric tells the full story. Reviewing AIRS's risk profile alongside its fundamentals and technical indicators provides a more complete picture.